semaglutide news november 28 2025 Are you eligible? Medicare's new GLP-1 Bridge program will cover certain weight-loss drugs starting this week. But as of now, the program isn't permanent: http://www.wgrz.com/article/news/nation-world/medicare-covering-glp-1-weight-loss-drugs-bridge Semaglutide versus placebo in individuals

While phase 3 TRIUMPH trials are outputting positive data, the drug must complete its full testing program and undergo a formal FDA safety and manufacturing review before it hits pharmacy shelves

Get Shapely Blog

Average sustainable weight loss is 1 to 2 pounds per week during active dose escalation, with individual variation based on metabolic factors and adherence to calorie awareness

It discusses how multifunctional nanoplatforms engage these features through pharmacokinetic and biodistribution-oriented design, vascular and stromal modulation, TME-responsive activation, immune-oriented intervention and imaging-guided therapy